Published on 4 Mar 2023 on Insider Monkey via Yahoo Finance
Revance Therapeutics, Inc. (NASDAQ:RVNC) Q4 2022 Earnings Call Transcript
Revance Therapeutics, Inc. (NASDAQ:RVNC) Q4 2022 Earnings Call Transcript February 28, 2023
Operator: Welcome to the Revance Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. Following managements' prepared remarks, we will hold a Q&A session. As a reminder, this call is being recorded today, Tuesday, February 28, 2023. I would now like to turn the conference over to Jessica Serra, Head of Investor Relations and ESG for Revance. Please go ahead.